FDA Warns Against Continued Use of Pain Reliever Propoxyphene

FDA warns against continued use of pain reliever propoxypheneThe U.S. Food and Drug Administration (FDA) has recently made an announcement warning patients of the dangers of the opioid pain reliever propoxyphene and calling on manufacturers to voluntarily recall the drug.

According to a recent press release issued by the FDA, data show links between continued usage of the drug and heart problems, including significant changes to the heart's electrical activity that can lead to abnormal heart rhythms. Abnormalities that the drug's usage is linked to include prolonged QT intervals and PR intervals and can be detected using an electrocardiogram (ECG).

In light of this data, the FDA has determined that the heart-health risks carried by the usage of the drug outweigh the pain relief benefits, and has recommended that patients who are currently using the drug talk to their medical care providers about switching to a different kind of pain reliever. It has also recommended that patients who are taking the drug and experiencing an abnormal heart rhythm, including dizzyness and heart palpitations, contact their healthcare provider immediately.

Brand names of drugs that contain propoxyphene include Darvon and Darvocet.